Eyenovia's IPO

Eyenovia raised a round of funding on January 25, 2018. Investors include Public.

Eyenovia is a specialty biopharmaceutical company building a portfolio of next generation eye therapies based on its proprietary delivery and formulation platform for microdosed therapies. Founded by …

Articles about Eyenovia's IPO: